On January 10, 2019, Aura Health Inc. (CNSX:BUZZ) closed the transaction. The company has issued 11,493,999 units for gross proceeds of CAD 1,724,099.85. The company paid finder fees of CAD 18,324 and issued 122,160 non-transferable finder warrants. The transaction included participation from Daniel Cohen, Chief Executive Officer of the company, who subscribed 400,000 units and Howard Brass, Chief Operating Officer of the company, who subscribed 100,000 units.